{
    "title": "Amag to divest two of three women's health drugs, CEO to step down",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7869525/Amag-divest-two-three-womens-health-drugs-CEO-step-down.html",
    "date": "2020-01-09",
    "keywords": [
        "health",
        "unit",
        "company",
        "amag",
        "treatment",
        "drug",
        "vyleesi",
        "quarter",
        "market",
        "executive",
        "officer",
        "investor",
        "libido",
        "pain",
        "interest",
        "william",
        "heiden",
        "role",
        "ceo",
        "president",
        "successor",
        "divestiture",
        "shift",
        "direction",
        "fall",
        "drugmaker",
        "june",
        "approval",
        "desire",
        "disorder",
        "revenue",
        "product",
        "injection",
        "risk",
        "birth",
        "panel",
        "food",
        "administration",
        "uncertainty",
        "durability",
        "makena",
        "promising",
        "pipeline",
        "physician",
        "consumer",
        "marketing",
        "statement",
        "caligan",
        "win",
        "october",
        "hedge",
        "fund",
        "anemia",
        "feraheme",
        "sachs",
        "co",
        "adviser",
        "reporting",
        "trisha",
        "roy",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}